Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Peer Reviewed
See detail*/es-'βɔl‐a‐/ v.intr. « quitter un lieu en s'élevant dans l'air ; se mouvoir dans l'air »
Baiwir, Esther ULg

in Buchi, Eva; Schweickard, Wolfgang (Eds.) Dictionnaire Étymologique Roman (DÉRom) (2014)

Detailed reference viewed: 14 (0 ULg)
See detailEsame ecografico del legamento sopraspinoso nel cavallo
Busoni, Valeria ULg; Denoix, J. M.

in Proceedings del Congresso annuale della Società Italiana di Ippologia (1996)

Detailed reference viewed: 26 (0 ULg)
Peer Reviewed
See detailEsame ecografico dell'apparato podotrocleare del cavallo
Busoni, Valeria ULg; Denoix, J. M.

in Proceedings du Congrès Annuel de la SIVE (1999)

Detailed reference viewed: 22 (1 ULg)
Peer Reviewed
See detailEsame ecografico dello scutum prossimale nel cavallo
Busoni, Valeria ULg; Denoix, J. M.

Poster (1996)

Detailed reference viewed: 51 (1 ULg)
Full Text
Peer Reviewed
See detailESC Forum on Drug Eluting Stents European Heart House, Nice, 27-28 September 2007.
Daemen, Joost; Simoons, Maarten L.; Wijns, William et al

in European heart journal (2009), 30(2), 152-61

Detailed reference viewed: 7 (1 ULg)
Full Text
Peer Reviewed
See detailESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.
Steg, Ph Gabriel; James, Stefan K.; Atar, Dan et al

in European Heart Journal (2012), 33(20), 2569-619

Detailed reference viewed: 21 (4 ULg)
Full Text
Peer Reviewed
See detailESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.
Ryden, Lars; Grant, Peter J.; Anker, Stefan D. et al

in Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease (2014), 11(3), 133-73

Detailed reference viewed: 11 (0 ULg)
Full Text
Peer Reviewed
See detailESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC).
Regitz-Zagrosek, Vera; Blomstrom Lundqvist, Carina; Borghi, Claudio et al

in European Heart Journal (2011), 32(24), 3147-97

Detailed reference viewed: 39 (2 ULg)
Full Text
Peer Reviewed
See detailESC working group on valvular heart disease position paper-heart valve clinics: organization, structure, and experiences
LANCELLOTTI, Patrizio ULg; Rosenhek, R; Pibarot, P et al

in European Heart Journal (2013)

Detailed reference viewed: 55 (11 ULg)
Full Text
Peer Reviewed
See detailESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Catapano, Alberico L; Reiner, Zeljko; De Backer, Guy et al

in Atherosclerosis (2011), 217(1), 3-46

Detailed reference viewed: 29 (0 ULg)
Full Text
Peer Reviewed
See detailESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).
Reiner, Zeljko; Catapano, Alberico L; De Backer, Guy et al

in European Heart Journal (2011), 32(14), 1769-818

Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to thrombosis is the foremost cause of premature mortality and of disability-adjusted life years (DALYs) in Europe, and ... [more ▼]

Cardiovascular disease (CVD) due to atherosclerosis of the arterial vessel wall and to thrombosis is the foremost cause of premature mortality and of disability-adjusted life years (DALYs) in Europe, and is also increasingly common in developing countries.1 In the European Union, the economic cost of CVD represents annually E192 billion1 in direct and indirect healthcare costs. The main clinical entities are coronary artery disease (CAD), ischaemic stroke, and peripheral arterial disease (PAD). The causes of these CVDs are multifactorial. Some of these factors relate to lifestyles, such as tobacco smoking, lack of physical activity, and dietary habits, and are thus modifiable. Other risk factors are also modifiable, such as elevated blood pressure, type 2 diabetes, and dyslipidaemias, or non-modifiable, such as age and male gender. These guidelines deal with the management of dyslipidaemias as an essential and integral part of CVD prevention. Prevention and treatment of dyslipidaemias should always be considered within the broader framework of CVD prevention, which is addressed in guidelines of the Joint European Societies' Task forces on CVD prevention in clinical practice.2 - 5 The latest version of these guidelines was published in 20075; an update will become available in 2012. These Joint ESC/European Atherosclerosis Society (EAS) guidelines on the management of dyslipidaemias are complementary to the guidelines on CVD prevention in clinical practice and address not only physicians [e.g. general practitioners (GPs) and cardiologists] interested in CVD prevention, but also specialists from lipid clinics or metabolic units who are dealing with dyslipidaemias that are more difficult to classify and treat. [less ▲]

Detailed reference viewed: 50 (0 ULg)
See detailL’escalier dans la principauté de Liège au XVIIIe siècle
Paquet, Pierre ULg

in Maisons d’Hier et d’Aujourd’hui (1988), 80

Description of some beautiful staircases in principality of Liège in the XVIIIth century.

Detailed reference viewed: 63 (4 ULg)